Your browser doesn't support javascript.
loading
Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.
Ballantyne, Christie M; Raichlen, Joel S; Cain, Valerie A.
Affiliation
  • Ballantyne CM; Baylor College of Medicine and the Methodist DeBakey Heart and Vascular Center, Houston, Texas 77030, USA. cmb@bcm.edu
J Am Coll Cardiol ; 52(8): 626-32, 2008 Aug 19.
Article in En | MEDLINE | ID: mdl-18702965
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Apolipoproteins B / Pyrimidines / Sulfonamides / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Fluorobenzenes / Cholesterol, HDL / Cholesterol, LDL Type of study: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Am Coll Cardiol Year: 2008 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Apolipoproteins B / Pyrimidines / Sulfonamides / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Fluorobenzenes / Cholesterol, HDL / Cholesterol, LDL Type of study: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Am Coll Cardiol Year: 2008 Document type: Article Affiliation country: United States Country of publication: United States